Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Two new gene-editing therapies may offer a functional cure, but cost and access issues could limit their use.
New research from Dana-Farber Cancer Institute has identified 116 genes as key molecular vulnerabilities for multiple myeloma.
For diseases like cancer, which arise when certain genes are over- or underexpressed, this could open a “new world” of treatment options.
A number of mutations can drive myeloproliferative neoplasms.
Scientists discover a single gene’s role in drug resistance and look for ways to re-sensitize tumors to chemotherapy.
The gene-editing tool can alter the DNA of human cells like a precise pair of scissors.
A panel of Hutch scientists talked gene therapy, big data and financial toxicity to reporters at the annual AAAS meeting.
Edited T cells survive and thrive in three patients in the first U.S. trial using this approach.
The new method may increase gene editing efficiency and safety for future use in human cells.
Scientists are preparing to bring DNA-editing tools to the clinic.
Scientists have discovered a swifter and more precise way to edit the genome of immune cells, opening doors for cancer and HIV therapies.
New immunotherapy approach could make engineering immune cells faster and cheaper.
How the idea for synthetic cells took Silicon Valley by storm
Feng Zhang, PhD, is recognized for his groundbreaking work in the field of CRISPR genome editing.
Fred Hutch experts lend their predictions for the coming year’s advances
New CRISPR-based genetic diagnostic tool that may make it faster and easier to diagnose acute and chronic diseases.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.